|
|
chromatin organization
|
GO:0006325 |
206 |
0.866
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.802
|
Worm |
|
|
rna processing
|
GO:0006396 |
105 |
0.776
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.771
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.625
|
Worm |
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.556
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.550
|
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.541
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.477
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.473
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.472
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.432
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.415
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.413
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.387
|
Worm |
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.375
|
Worm |
|
|
nucleic acid transport
|
GO:0050657 |
18 |
0.339
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.316
|
|
|
|
regulation of rna splicing
|
GO:0043484 |
37 |
0.302
|
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
43 |
0.299
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.292
|
|
|
|
alternative mrna splicing via spliceosome
|
GO:0000380 |
12 |
0.287
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.286
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.282
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.279
|
Worm |
|
|
mrna transport
|
GO:0051028 |
13 |
0.276
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.254
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.242
|
Worm |
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.239
|
|
|
|
rna localization
|
GO:0006403 |
23 |
0.229
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.217
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.215
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.211
|
|
|
|
regulation of mrna stability
|
GO:0043488 |
23 |
0.209
|
Human |
|
|
methylation
|
GO:0032259 |
134 |
0.206
|
|
|
|
regulation of mrna splicing via spliceosome
|
GO:0048024 |
32 |
0.205
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.203
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.202
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.200
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.196
|
Worm |
|
|
mrna processing
|
GO:0006397 |
63 |
0.195
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.186
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.185
|
Worm |
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.183
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.180
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.175
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.173
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.172
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.164
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.161
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.158
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.151
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.148
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.143
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.141
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.140
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.134
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.131
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.128
|
|
|
|
ribonucleoprotein complex subunit organization
|
GO:0071826 |
28 |
0.128
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.126
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.123
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.120
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.120
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.120
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.119
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.115
|
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
43 |
0.114
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.113
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.108
|
|
|
|
heterochromatin organization
|
GO:0070828 |
4 |
0.108
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.108
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.106
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.104
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.104
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.103
|
|
|
|
rna transport
|
GO:0050658 |
18 |
0.102
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.102
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.102
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.100
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.099
|
|
|
|
nucleobase containing compound transport
|
GO:0015931 |
27 |
0.092
|
|
|
|
spliceosomal complex disassembly
|
GO:0000390 |
1 |
0.091
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.088
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.087
|
|
|
|
nuclear export
|
GO:0051168 |
34 |
0.086
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.086
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.085
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.084
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.084
|
|
|
|
regulation of rna stability
|
GO:0043487 |
26 |
0.082
|
Human |
|
|
mrna export from nucleus
|
GO:0006406 |
11 |
0.079
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.078
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.077
|
|
|
|
establishment of rna localization
|
GO:0051236 |
18 |
0.077
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.077
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.077
|
|
|
|
mrna stabilization
|
GO:0048255 |
9 |
0.076
|
Human |
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.074
|
|
|
|
negative regulation of neuron projection regeneration
|
GO:0070571 |
3 |
0.073
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.073
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.072
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.071
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.069
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.069
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.069
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.069
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.068
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.067
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.066
|
|
|
|
dna templated transcription termination
|
GO:0006353 |
4 |
0.066
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.065
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.065
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.064
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.064
|
|
|
|
protein desumoylation
|
GO:0016926 |
2 |
0.063
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.063
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.063
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.063
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.062
|
|
|
|
pore complex assembly
|
GO:0046931 |
3 |
0.062
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.062
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.061
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.061
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.059
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.059
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.059
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.058
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.058
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.057
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.056
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.056
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.056
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.055
|
|
|
|
protein complex disassembly
|
GO:0043241 |
40 |
0.053
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.053
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.053
|
Human |
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.053
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.052
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.052
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.052
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.052
|
|
|
|
negative regulation of dna templated transcription termination
|
GO:0060567 |
1 |
0.052
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.051
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.051
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.051
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.050
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.048
|
Human |
|
|
b cell activation
|
GO:0042113 |
161 |
0.047
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.047
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.046
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.045
|
|
|
|
maturation of 5 8s rrna from tricistronic rrna transcript ssu rrna 5 8s rrna lsu rrna
|
GO:0000466 |
1 |
0.045
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.045
|
|
|
|
translation
|
GO:0006412 |
93 |
0.044
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.043
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.043
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.043
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
29 |
0.043
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.043
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.042
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.042
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.041
|
|
|
|
double strand break repair
|
GO:0006302 |
48 |
0.041
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.041
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.041
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.041
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.041
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.041
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.041
|
Worm |
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.040
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.040
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.040
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.040
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.039
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.039
|
|
|
|
regulation of transcription by chromatin organization
|
GO:0034401 |
0 |
0.039
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.039
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.039
|
|
|
|
regulation of alternative mrna splicing via spliceosome
|
GO:0000381 |
8 |
0.038
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.038
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.038
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.038
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.037
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.037
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.037
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.037
|
|
|
|
nucleus organization
|
GO:0006997 |
45 |
0.035
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.035
|
|
|
|
atp dependent chromatin remodeling
|
GO:0043044 |
9 |
0.035
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.035
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.034
|
|
|
|
positive regulation of cell cycle phase transition
|
GO:1901989 |
17 |
0.034
|
|
|
|
kinetochore organization
|
GO:0051383 |
2 |
0.034
|
|
|
|
oocyte development
|
GO:0048599 |
33 |
0.034
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.034
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.034
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.033
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.033
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.033
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.032
|
|
|
|
rna stabilization
|
GO:0043489 |
9 |
0.032
|
Human |
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.032
|
|
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
17 |
0.032
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.032
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.032
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.031
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.031
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.031
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.031
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.031
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.030
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.030
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.030
|
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.029
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.029
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.029
|
|
|
|
ribonucleoprotein complex disassembly
|
GO:0032988 |
3 |
0.029
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.029
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.029
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.029
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.028
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.028
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.028
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.028
|
|
|
|
nls bearing protein import into nucleus
|
GO:0006607 |
2 |
0.028
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.028
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.028
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.028
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.028
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.028
|
|
|
|
mitotic sister chromatid segregation
|
GO:0000070 |
14 |
0.027
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.027
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.027
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.027
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.027
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.027
|
|
|
|
peptidyl arginine omega n methylation
|
GO:0035247 |
2 |
0.027
|
|
|
|
protein localization to chromosome centromeric region
|
GO:0071459 |
1 |
0.027
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.026
|
|
|
|
maternal placenta development
|
GO:0001893 |
20 |
0.026
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.026
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.026
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.025
|
|
|
|
heterochromatin assembly
|
GO:0031507 |
2 |
0.025
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.025
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.025
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.025
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.025
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
30 |
0.025
|
|
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
19 |
0.025
|
|
|
|
positive regulation of mrna metabolic process
|
GO:1903313 |
17 |
0.025
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.024
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.024
|
|
|
|
negative regulation of gene expression epigenetic
|
GO:0045814 |
15 |
0.024
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.024
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.024
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.024
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.024
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.023
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.023
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.023
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.023
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.023
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.023
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.023
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.023
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.022
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.022
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.022
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
35 |
0.022
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.022
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.022
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.022
|
|
|
|
centrosome organization
|
GO:0051297 |
26 |
0.022
|
|
|
|
microtubule organizing center organization
|
GO:0031023 |
28 |
0.022
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.022
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.021
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.021
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.021
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.021
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.021
|
|
|
|
organism emergence from protective structure
|
GO:0071684 |
4 |
0.021
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.021
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.021
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.020
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.020
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.020
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.020
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.020
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.020
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.020
|
|
|
|
chromatin assembly
|
GO:0031497 |
13 |
0.020
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.019
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.019
|
Worm |
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.019
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.019
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.019
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.019
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.019
|
|
|
|
positive regulation of dendritic spine morphogenesis
|
GO:0061003 |
8 |
0.019
|
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.019
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.019
|
|
|
|
histone h3 deacetylation
|
GO:0070932 |
8 |
0.019
|
|
|
|
chromatin silencing at rdna
|
GO:0000183 |
3 |
0.018
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.018
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.018
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.018
|
Worm |
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.018
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
16 |
0.018
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.018
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.018
|
|
|
|
spliceosomal complex assembly
|
GO:0000245 |
6 |
0.018
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.018
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.018
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.017
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.017
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.017
|
|
|
|
somatic recombination of immunoglobulin gene segments
|
GO:0016447 |
42 |
0.017
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.017
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.017
|
|
|
|
rrna containing ribonucleoprotein complex export from nucleus
|
GO:0071428 |
1 |
0.017
|
|
|
|
regulation of microtubule based process
|
GO:0032886 |
52 |
0.017
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.017
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.017
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.016
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.016
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.016
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.016
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.016
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.016
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.016
|
|
|
|
regulation of neuron projection regeneration
|
GO:0070570 |
7 |
0.016
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.015
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.015
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.015
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.015
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.015
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.015
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.015
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.015
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.015
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.015
|
|
|
|
spindle organization
|
GO:0007051 |
28 |
0.015
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.015
|
|
|
|
maternal process involved in female pregnancy
|
GO:0060135 |
32 |
0.015
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.015
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.015
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.015
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.015
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.015
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.014
|
|
|
|
somatic diversification of immunoglobulins involved in immune response
|
GO:0002208 |
36 |
0.014
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.014
|
|
|
|
positive regulation of dendrite development
|
GO:1900006 |
21 |
0.014
|
|
|
|
positive regulation of cytoplasmic transport
|
GO:1903651 |
40 |
0.014
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.014
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
35 |
0.014
|
|
|
|
somatic diversification of immunoglobulins
|
GO:0016445 |
43 |
0.014
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.014
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.014
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.014
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.014
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.014
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.014
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.014
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.014
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.014
|
|
|
|
negative regulation of translation
|
GO:0017148 |
22 |
0.014
|
|
|
|
viral transcription
|
GO:0019083 |
3 |
0.014
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.014
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.014
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.013
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.013
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.013
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway
|
GO:2001243 |
34 |
0.013
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.013
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.013
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.013
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.013
|
|
|
|
rna export from nucleus
|
GO:0006405 |
15 |
0.013
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.013
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.013
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.013
|
|
|
|
sister chromatid segregation
|
GO:0000819 |
20 |
0.013
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.013
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.013
|
|
|
|
response to heat
|
GO:0009408 |
27 |
0.013
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.013
|
|
|
|
histone deacetylation
|
GO:0016575 |
26 |
0.012
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.012
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.012
|
|
|
|
maintenance of protein location in nucleus
|
GO:0051457 |
2 |
0.012
|
|
|
|
regulation of microtubule cytoskeleton organization
|
GO:0070507 |
37 |
0.012
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.012
|
|
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.012
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.012
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.012
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.012
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.012
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.012
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.012
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.012
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.012
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.012
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.012
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.012
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.012
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.012
|
|
|
|
dna conformation change
|
GO:0071103 |
37 |
0.012
|
|
|
|
positive regulation of nucleocytoplasmic transport
|
GO:0046824 |
30 |
0.012
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.012
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.012
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.012
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.011
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.011
|
|
|
|
positive regulation of intrinsic apoptotic signaling pathway
|
GO:2001244 |
25 |
0.011
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.011
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.011
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.011
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.011
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.011
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.011
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.011
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.011
|
|
|
|
localization within membrane
|
GO:0051668 |
4 |
0.011
|
|
|
|
positive regulation of protein localization to nucleus
|
GO:1900182 |
30 |
0.011
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.011
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.011
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.011
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.011
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.011
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.010
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.010
|
|
|
|
chromatin remodeling at centromere
|
GO:0031055 |
2 |
0.010
|
|
|
|
modification by host of symbiont morphology or physiology
|
GO:0051851 |
12 |
0.010
|
|
|
|
mitotic spindle organization
|
GO:0007052 |
10 |
0.010
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.010
|
|
|
|
protein modification by small protein removal
|
GO:0070646 |
21 |
0.010
|
|
|
|
response to sterol
|
GO:0036314 |
4 |
0.010
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.010
|
|
|
|
negative regulation of rna splicing
|
GO:0033119 |
12 |
0.010
|
|
|
|
nuclear mrna surveillance
|
GO:0071028 |
1 |
0.010
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.010
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.010
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.010
|
|